Novo Nordisk

We are committed to #changingdiabetes & possibilities in #haemophilia. Sharing stories & updates from around the world. Disclaimer on our site

Suggest edits

Founded

1923

Follow us

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 1

Apps 1

Add info

Team Size

10000+

Employees

I work here

Location

Denmark

Headquarters

Explore Denmark

Novo Nordisk to Buy Corvidia Therapeutics, for Up To $2.1 Billion

Novo Nordisk To Buy Corvidia Therapeutics For Up To $2.1B

Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia

Novo Nordisk Joins Other Drugmakers With Gains on Virus Stockpiling

Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy

Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate

Novo Nordisk targets bigger slice of diabetes market with new tablet

Novo Nordisk to cut insulin prices in the U.S.

Denmark's Novo Nordisk files lawsuit against Mylan over patent

Novo Nordisk profit tops forecast as new diabetes drug shines

Taiwanese startup Health2Sync inks Novo Nordisk deal to drive growth in Japan

Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools

Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk

Novo Nordisk Is on High But Shaky Ground

Health Earnings

Novo Nordisk's Deal Discipline Is Behind the Times

Health Stock markets

Novo Goes Public With $3.1 Billion Bid to Pressure Ablynx

Health Strategy

Novo Nordisk Diabetes Drug Beats Lilly’s Trulicity in Head-to-Head Test

Health Earnings

What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?

Health

5 Companies We'd Buy and Hold for the Next 20 Years

Earnings Stock markets

Index

By TNW

Novo Nordisk

Novo Nordisk

Overview

Investments 1

Apps 1

Novo Nordisk to Buy Corvidia Therapeutics, for Up To $2.1 Billion

Novo Nordisk To Buy Corvidia Therapeutics For Up To $2.1B

Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia

Novo Nordisk Joins Other Drugmakers With Gains on Virus Stockpiling

Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy

Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate

Novo Nordisk targets bigger slice of diabetes market with new tablet

Novo Nordisk to cut insulin prices in the U.S.

Denmark's Novo Nordisk files lawsuit against Mylan over patent

Novo Nordisk profit tops forecast as new diabetes drug shines

Taiwanese startup Health2Sync inks Novo Nordisk deal to drive growth in Japan

Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools

Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk

Novo Nordisk Is on High But Shaky Ground

Novo Nordisk's Deal Discipline Is Behind the Times

Novo Goes Public With $3.1 Billion Bid to Pressure Ablynx

Novo Nordisk Diabetes Drug Beats Lilly’s Trulicity in Head-to-Head Test

What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?

5 Companies We'd Buy and Hold for the Next 20 Years

Novo Nordisk A/S Injecting Future Sales